Lupin Limited
LUPIN
Rankning i aktier
#2104
Lupin Limited is a pharmaceutical firm dedicated to the creation,... Lupin Limited is a pharmaceutical firm dedicated to the creation, manufacturing, commercialization, and distribution of a wide array of branded and generic medications, biotechnology items, and active pharmaceutical ingredients (APIs). Its comprehensive product portfolio addresses diverse therapeutic categories, including cardiovascular health, diabetes management, asthma, pediatric care, central nervous system disorders, gastrointestinal issues, anti-infectives, nonsteroidal anti-inflammatory drug (NSAID) therapy, respiratory ailments, women's health, and anti-tuberculosis treatments. Beyond its primary offerings, Lupin also supplies biosimilars and over-the-counter (OTC) medicines, alongside specialized pharmaceutical products. The company actively pursues drug discovery and development initiatives focused on oncology, immunology, and metabolic disorders, complementing these efforts with bio-clinical research. Lupin Limited maintains an extensive operational network comprising 18 laboratories, 280 LupiMitra collection centers, and 450 pick-up points. Its global presence extends across numerous countries, such as India, the United States, the United Kingdom, South Africa, Australia, the Philippines, Germany, the Netherlands, Mexico, and Brazil. Originally named Lupin Chemicals Limited, the company adopted its current identity, Lupin Limited, in 2001 following its merger with Lupin Laboratories Limited. Established in 1968, Lupin Limited is based in Mumbai, India.
Aktiekurs
$21.40
Senast synkroniserad: 2026-10-19
Marknadsvärde
$9.79B
Förändring (1 dag)
-1.36%
Förändring (1 år)
-3.25%
Land
IN
Handel Lupin Limited (LUPIN)
Kategori
Healthcare
EPS för Lupin Limited (LUPIN)
EPS per June 2026 TTM: $1.34
Enligt Lupin Limiteds senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $1.34. Vid slutet av 2024 hade bolaget ett EPS på $0.50, en ökning jämfört med EPS från 2023 som var $0.12.
EPS-historik för Lupin Limited från 2004 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $1.34 | 58.99% |
| 2025 | $0.84 | 66.83% |
| 2024 | $0.50 | 338.14% |
| 2023 | $0.12 | -125.96% |
| 2022 | $-0.44 | -220.92% |
| 2021 | $0.37 | -413.07% |
| 2020 | $-0.12 | -171.84% |
| 2019 | $0.16 | 90.87% |
| 2018 | $0.09 | -90.23% |
| 2017 | $0.87 | 15.30% |
| 2016 | $0.76 | -11.63% |
| 2015 | $0.86 | -3.94% |
| 2014 | $0.89 | 65.13% |
| 2013 | $0.54 | 41.15% |
| 2012 | $0.38 | -11.79% |
| 2011 | $0.43 | 23.16% |
| 2010 | $0.35 | 47.14% |
| 2009 | $0.24 | -4.08% |
| 2008 | $0.25 | 43.29% |
| 2007 | $0.17 | 84.16% |
| 2006 | $0.09 | 84.60% |
| 2005 | $0.05 | 7.55% |
| 2004 | $0.05 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -58.35% |
IN
|
